Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | LDHA | P00338 | 1/20 | 0.31 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28657159 | 0.84 | KDM4E (0.41) | ALDH1A1THRBRECQLCYP2D6CYP2C19 | |
| SCHEMBL8754570 | 0.72 | — | — | |
| SCHEMBL42490 | 0.69 | — | — | |
| SCHEMBL5933862 | 0.69 | — | — | |
| SCHEMBL612192 | 0.69 | — | — | |
| SCHEMBL24042401 | 0.69 | ALDH1A1 (0.41) | ALDH1A1THRBRECQLCYP2C19 | |
| SCHEMBL7525656 | 0.69 | CYP2D6 (0.41) | ALDH1A1THRBRECQLCYP2D6CYP2C19 | |
| SCHEMBL968334 | 0.69 | — | — | |
| SCHEMBL28719441 | 0.69 | CYP2D6 (0.41) | ALDH1A1THRBRECQLCYP2D6CYP2C19 | |
| Bromide SCHEMBL11752199 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210246271-A1 | POLYMERIC STABILIZING FORMULATIONS | NANO PRECISION MEDICAL, INC. (US) | 2021-08-12 | — | — | US | claimed |
| US-11021576-B2 | Polymeric stabilizing formulations | NANO PRECISION MEDICAL, INC. (US) | 2021-06-01 | — | — | US | claimed |
| US-20200040140-A1 | POLYMERIC STABILIZING FORMULATIONS | NANO PRECISION MEDICAL, INC. (US) | 2020-02-06 | — | — | US | claimed |
| US-10479868-B2 | Polymeric stabilizing formulations | NANO PRECISION MEDICAL, INC. (US) | 2019-11-19 | — | — | US | claimed |
| US-20170274089-A1 | POLYMERIC STABILIZING FORMULATIONS | NANO PRECISION MEDICAL, INC. | 2017-09-28 | — | — | US | claimed |
| WO-2017135893-A1 | AQUEOUS DENDRITIC AMINE COATINGS | NIPSEA TECHNOLOGIES PTE LTD (SG) | 2017-08-10 | — | — | WO | claimed |
| WO-2016037128-A1 | POLYMERIC STABILIZING FORMULATIONS | NANO PRECISION MEDICAL, INC. (US) | 2016-03-10 | — | — | WO | claimed |
| EP-2600844-A2 | INTERIOR FUNCTIONALIZED HYPERBRANCHED DENDRON-CONJUGATED NANOPARTICLES AND USES THEREOF | University Of Houston (US) | 2013-06-12 | — | — | EP | claimed |
| WO-2012018383-A2 | INTERIOR FUNCTIONALIZED HYPERBRANCHED DENDRON-CONJUGATED NANOPARTICLES AND USES THEREOF | UNIVERSITY OF HOUSTON (US) | 2012-02-09 | — | — | WO | claimed |
| US-20120029062-A1 | Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses thereof | HOUSTON, UNIVERSITY OF | 2012-02-02 | — | — | US | claimed |
| US-7985424-B2 | Dendritic polymers with enhanced amplification and interior functionality | DENDRITIC NANOTECHNOLOGIES INC. (US) | 2011-07-26 | — | — | US | claimed |
| US-7981444-B2 | Dendritic polymers with enhanced amplification and interior functionality | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2011-07-19 | — | — | US | claimed |
| EP-2325236-A1 | Dendritic polymers with enhanced amplification and interior functionality | Dendritic Nanotechnologies Inc. (US) | 2011-05-25 | — | — | EP | claimed |
| EP-1737899-A4 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | DENDRITIC NANOTECHNOLOGIES INC (US) | 2008-03-05 | — | — | EP | claimed |
| US-20070298006-A1 | Dendritic Polymers With Enhanced Amplification and Interior Functionality | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2007-12-27 | — | — | US | claimed |
| US-20070244296-A1 | Dendritic Polymers with Enhanced Amplification and Interior Functionality | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2007-10-18 | — | — | US | claimed |
| EP-1737899-A2 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | Dendritic Nanotechnologies, Inc. (US) | 2007-01-03 | — | — | EP | claimed |
| WO-2006065266-A9 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | DENDRITIC NANOTECHNOLOGIES INC (US) | 2006-12-21 | — | — | WO | claimed |
| WO-2006065266-A2 | DENDRITIC POLYMERS WITH ENHANCED AMPLIFICATION AND INTERIOR FUNCTIONALITY | DENDRITIC NANOTECHNOLOGIES, INC. (US) | 2006-06-22 | — | — | WO | claimed |
| US-5573757-A | TOPICAL GEL | ALLIANCE PHARMACEUTICAL CORP. (US) | 1996-11-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170274089-A1 | POLYMERIC STABILIZING FORMULATIONS | IAPP, INSR, GPR119 | ALDH1A1 2610/4885THRB 3948/4885RECQL 3481/4885 |
| US-11021576-B2 | Polymeric stabilizing formulations | IAPP, INSR, GPR119 | ALDH1A1 2610/4885THRB 3948/4885RECQL 3481/4885 |
| US-20070298006-A1 | Dendritic Polymers With Enhanced Amplification and Interior Functionality | MYD88, TLR3, TMEM97 | ALDH1A1 2720/4885THRB 3966/4885RECQL 518/4885 |
| US-10479868-B2 | Polymeric stabilizing formulations | IAPP, INSR, GPR119 | ALDH1A1 2610/4885THRB 3948/4885RECQL 3481/4885 |
| US-20200040140-A1 | POLYMERIC STABILIZING FORMULATIONS | IAPP, INSR, GPR119 | ALDH1A1 2610/4885THRB 3948/4885RECQL 3481/4885 |
| US-20210246271-A1 | POLYMERIC STABILIZING FORMULATIONS | VEGFA, CD44, CFTR | ALDH1A1 3181/4885THRB 4811/4885RECQL 1032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.